Identifying the Role of Clinical Biomarkers in Genome Editing Therapeutics for Sickle Cell Disease
Time: 3:30 pm
day: Day Two
Details:
• Biomarkers to support efficacy of gene editing therapies to treat sickle cell disease
• Specialized biomarker discovery to assess disease pathophysiology
• Importance and opportunity biomarkers bring to accelerate clinical development
